NCT00073476终止2 期
A Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of a 72-Hour Infusion of CP-101,606 in Subjects With Acute Ischemic Stroke.
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 发起方
- Pfizer
- 入组人数
- 300
- 试验地点
- 30
- 主要终点
- No or minimal neurological deficit at last visit
研究概览
简要总结
The purpose of this study is to determine whether a new research medication is effective and safe for the treatment of acute stroke when given within 6 hours of the onset of stroke.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 40 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Males & females age 40-90 years
- •Enrolled in study within 6 hours of onset of stroke symptoms
- •Willing to sign informed consent form
- •No significant disabilities prior to stroke
排除标准
- •Treatment with t-PA (tissue plasminogen activator)
- •Premorbid modified rankin scale score of 2 or more
结局指标
主要结局
No or minimal neurological deficit at last visit
Marked neurological improvement at last visit
次要结局
- Modified Rankin scale at last visit
- Mortality
- Safety assessments
研究者
研究点 (30)
Loading locations...
相似试验
已完成
4 期
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New DrugEpilepsy, Tonic-ClonicNCT00043901GlaxoSmithKline141
已完成
2 期
Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003)Urinary IncontinenceOveractive BladderNCT00290563Vyne Therapeutics Inc.557
已完成
3 期
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine BleedingMetrorrhagiaNCT00307801Bayer231
已完成
3 期
Efficacy and Safety Study for the Treatment of Dysfunctional Uterine BleedingMetrorrhagiaNCT00293059Bayer190
已完成
3 期
An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)Diabetes Mellitus, Type 2NCT00094757Merck Sharp & Dohme LLC521